Inflation Devices Market Size, Trends and Forecast to 2030

The Inflation Devices Market size is expected to reach US$ 7.96 billion by 2030, from US$ 4.64 billion in 2023, at a CAGR of 8% during the forecast period. Inflation devices are used to inflate and deflate balloon catheters during angioplasty procedures to treat blocked arteries. The advantages of these devices include precise inflation control and enhanced patient safety. The Inflation Devices Market is segmented by product, application, end-user and region. By product, the syringes segment is expected to dominate the market owing to the growing preference for disposable inflation devices.

Inflation Devices Market Regional Insights

North America is expected to be the largest market for Inflation Devices Market during the forecast period, accounting for over 35.2% of the market share in 2023. The growth of the market in North America is attributed to the presence of key players and increasing prevalence of cardiovascular diseases in the region.

The Europe market is expected to be the second-largest market for Inflation Devices Market, accounting for over 28.7% of the market share in 2023. The growth of the market in Europe is attributed to the rising geriatric population and favorable reimbursement policies.

The Asia Pacific market is expected to be the fastest-growing market for Inflation Devices Market, with a CAGR of over 23.5% during the forecast period. The growth of the market in Asia Pacific is attributed to the improving healthcare infrastructure and increasing healthcare expenditure in the region.

Figure 1. Inflation Devices Market Share (%), By Region, 2023

Inflation Devices Market Drivers

Increasing prevalence of cardiovascular diseases

The rising prevalence of cardiovascular diseases such as coronary artery disease and heart failure is driving the demand for angioplasty procedures, which is subsequently fueling the growth of the inflation devices market. According to WHO, cardiovascular disease is the number one cause of death globally, responsible for over 17 million deaths per year.

Favorable reimbursement scenario

The availability of reimbursement for angioplasty procedures is increasing the adoption of inflation devices. Public and private insurance providers are increasingly covering expenses related to cardiovascular treatments due to the risks associated with heart diseases.

Rising minimally invasive surgeries

The shift from traditional open surgeries toward minimally invasive procedures is boosting the adoption of inflation devices used in balloon based surgeries such as angioplasty. Minimally invasive surgeries reduce hospital stays and costs.

Increasing healthcare expenditure

The growing healthcare spending by governments and individuals globally is leading to higher adoption of advanced cardiovascular devices and treatments, thereby driving the inflation devices market. According to CMS, the healthcare spending in the US is estimated to reach USD 6.2 trillion by 2028.

Inflation Devices Market Opportunities

Growth prospects in emerging economies

Rising prevalence of CVDs along with improving healthcare infrastructure in developing nations such as India, China, Brazil, etc. is expected to create significant opportunities for inflation device manufacturers. Favorable regulatory scenario is also attracting key players to emerging markets.

Development of smart inflation devices

Integration of technologies such as IoT, artificial intelligence, and machine learning in inflation devices can help improve patient monitoring and enable data-driven, precise inflation control. Companies are working on developing connected, smart inflation devices.

Increasing adoption of disposable devices

The growing trend of using disposable devices to reduce cross-contamination risks presents lucrative opportunities for market players. Disposable inflation devices eliminate maintenance and sterilization costs.

Expansion of application areas

The widening clinical applications of inflation devices in procedures such as balloon sinuplasty, airway dilation, balloon gastrointestinal procedures, etc. is creating new avenues for market growth.

Inflation Devices Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2023:	US$ 4.64 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8%	2030 Value Projection:	US$ 7.96 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
Segments covered:	By Product: Syringes, Bags, Tubing, Balloons, Others By Application: Angioplasty, Gastroenterology, Laparoscopy, Urology, Others By End-User: Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Others
Companies covered:	Medtronic, Boston Scientific, Abbott Laboratories , Teleflex, ConvaTec, Smiths Group, Cook Medical, B. Braun Melsungen, Cardinal Health, Stryker
Growth Drivers:	Increasing prevalence of cardiovascular diseases Favorable reimbursement scenario Rising minimally invasive surgeries Increasing healthcare expenditure
Restraints & Challenges:	High cost of advanced inflation devices Lack of trained professionals Stringent regulatory policies

Inflation Devices Market Trends

Shift toward digital inflation technologies

Manufacturers are increasingly developing digital inflation devices integrated with electronic pressure sensors, LCD displays, and intuitive user controls. Digital interfaces allow improved visibility, accuracy, and control over inflation.

Focus on patient safety and comfort

Key market trends include the incorporation of safety mechanisms such as pressure relief valves, ergonomic lightweight handles, and mechanisms to reduce balloon deflation time. Companies are designing patient-friendly inflation devices.

Development of intuitive handheld devices

Trending product innovations include compact, lightweight handheld inflation devices with advanced digital interfaces, making them easier to handle and transport. Intuitive display and control panels improve usability.

Increasing preference for intuitive mechanics

Mechanically simpler, easy-to-operate inflation devices with fewer components are being preferred. quick inflation/deflation, better ergonomics, and enhanced reliability.

Inflation Devices Market Restraints

High cost of advanced inflation devices

The high cost of technologically advanced digital inflation devices coupled with low awareness in developing regions is restraining market growth to some extent. The complex integration process is an obstacle.

Lack of trained professionals

The shortage of skilled cardiologists and technicians, especially in emerging economies, is hampering the adoption of inflation devices. Proper training is required to operate inflation devices efficiently.

Stringent regulatory policies

The stringent approval and certification processes mandated by regulatory bodies like FDA and CE are challenging for manufacturers. Delayed approvals can restrain market growth.

Figure 2. Global Inflation Devices Market Share (%), By Product type, 2023

Recent Developments

New Product Launches

In 2022, Medtronic launched the RBP Black Hawk Digital Inflation Device designed for optimal visibility and single-hand control. It provides personalized inflation protocols.

In 2021, Merit Medical launched the BasixTOUCH Inflation Device, a compact and lightweight inflation device with an intuitive touchscreen interface.

In 2020, Boston Scientific released the Maverick Interactive Inflation System, offering health-care professionals more visibility and control during balloon inflation.

Acquisitions and Partnerships

In 2022, Smiths Medical partnered with Ivenix to integrate infusion technologies with Ivenix's infusion system.

In 2021, Baxter acquired Smiths Medical for USD 2.8 Bn to strengthen its MedSurg segment through addition of infusion pumps.

In 2020, ConvaTec acquired Cytosorbents's US rights for CytoSorb to expand into critical care.

Top companies in Inflation Devices Market

Medtronic
Boston Scientific
Abbott Laboratories
Teleflex
ConvaTec
Smiths Group
Cook Medical
B. Braun Melsungen
Cardinal Health
Stryker

*Definition: The Inflation Devices Market refers to the global market for medical devices used to inflate and deflate balloon catheters during various minimally invasive surgical procedures and examinations. Inflation devices allow controlled and safe inflation/deflation of angioplasty and other balloons during cardiovascular interventions as well as balloons used for gastrointestinal, urological, gynecological, and ear-nose-throat procedures. They are an indispensable part of balloon dilatation procedures. The most common types of inflation devices include syringes, pumps, bags, and automated inflation systems. Key end-users are hospitals, ambulatory surgery centers, and diagnostic imaging centers. With the growing incidence of cardiovascular diseases and preference for minimally invasive surgeries, the global demand for advanced and safe inflation devices is increasing significantly.

Frequently Asked Questions

The key factors hampering the growth of the Inflation Devices Market are high cost of devices, availability of alternative treatments, lack of trained professionals, unfavorable reimbursement policies in some regions, risks associated with invasive procedures, and limitations in treating complex cases.

The major factors driving the Market growth are rising prevalence of cardiovascular diseases and GI disorders, increasing adoption of minimally invasive surgeries, technological advancements in inflation devices, growing elderly population, and favorable reimbursement policies.

The digital inflation devices segment accounts for the largest share in the Market owing to benefits like automatic pressure sensing and control.

The major players operating in the Market are Becton, Dickinson and Company, Merit Medical Systems, Boston Scientific Corporation, Medtronic, Acclarent, Cook Medical, and Conmed Corporation.

North America is expected to dominate the Market during the forecast period owing to high adoption of minimally invasive procedures and new product launches.